400 related articles for article (PubMed ID: 15574475)
1. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Kugelberg E; Löfmark S; Wretlind B; Andersson DI
J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
Lee JK; Lee YS; Park YK; Kim BS
Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Jalal S; Wretlind B
Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
[TBL] [Abstract][Full Text] [Related]
4. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
Sinha S; Chattopadhyay S; Bhattacharya SK; Nair GB; Ramamurthy T
Res Microbiol; 2004 Dec; 155(10):827-9. PubMed ID: 15567276
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
Shen JL; Zhu DM; Wang MG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
[TBL] [Abstract][Full Text] [Related]
7. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
[TBL] [Abstract][Full Text] [Related]
8. [Study on the molecular mechanism of quinolone resistance in Shigellae spp].
Zhu JY; Duan GC; Xi YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):245-7. PubMed ID: 15200940
[TBL] [Abstract][Full Text] [Related]
9. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
Capilla S; Ruiz J; Goñi P; Castillo J; Rubio MC; Jiménez de Anta MT; Gómez-Lus R; Vila J
J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between mutation of GyrA and ParC genes and quinolone resistance in Neisseria gonorrhoeae].
Xie P; Mi ZH; Li Q; Zhang J; Xiao CY
Zhonghua Nan Ke Xue; 2003; 9(4):275-8. PubMed ID: 12931370
[TBL] [Abstract][Full Text] [Related]
13. Quinolone resistance mechanisms in pneumococci.
Eliopoulos GM
Clin Infect Dis; 2004 May; 38 Suppl 4():S350-6. PubMed ID: 15127369
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
15. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
16. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
Davies TA; Yee YC; Goldschmidt R; Bush K; Sahm DF; Evangelista A
J Antimicrob Chemother; 2006 Mar; 57(3):437-42. PubMed ID: 16431861
[TBL] [Abstract][Full Text] [Related]
17. Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains.
Valdezate S; Vindel A; Saéz-Nieto JA; Baquero F; Cantón R
J Antimicrob Chemother; 2005 Jul; 56(1):220-3. PubMed ID: 15928010
[TBL] [Abstract][Full Text] [Related]
18. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation.
Randall LP; Coldham NG; Woodward MJ
J Antimicrob Chemother; 2005 Oct; 56(4):619-23. PubMed ID: 16141278
[TBL] [Abstract][Full Text] [Related]
19. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
